Interaction of ventriculoperitoneal shunt and baclofen pump

Child's Nervous System

Volumn 23, Issue 7, 2007, Pages 733-738

  Fulkerson, Daniel H ^a   Boaz, Joel C ^a   Luerssen, Thomas G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrospinal fluid shunt; Complication; Hydrocephalus; Intrathecal baclofen; Low pressure hydrocephalus; Spasticity

Indexed keywords

ANTIBIOTIC AGENT; BACLOFEN;

ANAMNESIS; ARTICLE; BRAIN VENTRICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CATHETER OCCLUSION; CEREBRAL PALSY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL DISORDER; DRUG CLEARANCE; FEEDING DISORDER; FEMALE; HUMAN; HYDROCEPHALUS; INFUSION PUMP; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SHUNT INFECTION; TREATMENT FAILURE;

BACLOFEN; BRAIN; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EQUIPMENT FAILURE; FEMALE; HUMANS; HYDROCEPHALUS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; SPINAL CORD;

EID: 34249882167     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-007-0298-5     Document Type: Article

References (25)

1. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270:2475-2477
2. Albright AL, Awaad Y, Muhonen M, Boydston W, Gilmartin R, Krach L et al (2004) Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101(Pediatrics 1):64-68
3. Albright AL, Ferson S, Carlos S (2005) Occult hydrocephalus in children with cerebral palsy. Neurosurgery 56:93-97
4. Armstrong RW, Steinbok P, Cochrane DD, Kube S, Fife S, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87:409-414
5. Coffey R, Edgar T, Francisco G, Graziani V, Meythaler J, Ridgely P et al (2002) Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83:735-741
6. Coffey JR, Cahill D, Steers W, Park T, Ordia J, Meythaler J et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226-232
7. Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Safety 27:799-818
8. Delhaas E, Brouwers J (1991) Intrathecal baclofen overdose: Report of 7 events in 5 patients and review of the literature. Int J Clin Pharmacol Ther Toxicol 29:274-280
9. Dias M, Li V, Pollina J (1999) Low-pressure shunt "malfunction" following lumbar puncture in children with shunted obstructive hydrocephalus. Pediatr Neurosurg 30:146-150
10. Gerszten P, Albright AL, Barry M (1997) Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 27:40-44
11. Gianino J, York M, Paice J, Shott S (1998) Quality of life: Effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 30:47-54
12. Gilmartin R, Bruce D, Storrs B, Abbott R, Krach L, Ward J et al (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15:71-77
13. Gooch J, Oberg W, Grams B, Ward L, Walker M (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39:1-6
14. Kroin JS (1992) Intrathecal drug administration: Present use and future trends. Clin Pharmacokinet 22:319-326
15. Muller H (1988) Pharmacokinetics of intrathecal baclofen. In: Muller H, Zierski J, Penn RD (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg New York, pp 223-225
16. Orida J, Fischer E, Adamski E, Spatz E (1996) Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 85:452-457
17. Pang D, Altschuler E (1994) Low-pressure hydrocephalic state and viscoelastic alterations in the brain. Neurosurgery 35:643-655
18. Penn R, Kroin J (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2:125-127
19. Rekate H (1992) Brain turgor (Kb): Intrinsic property of the brain to resist distortion. Pediatr Neurosurg 18:257-262
20. Sallerin-Caute B, Lazorthes Y, Monsarrat B, Cros J, Bastide R (1991) CSF baclofen levels after intrathecal administration for severe spasticity. Eur J Clin Pharmacol 40:363-365
21. Sampson FC, Hayward A, Evans G, Morton R, Collett B (2002) Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96:1052-1057
22. Tubbs RS, Law C, Oakes WJ, Grabb P (2004) Acquired Chiari I malformation following baclofen pump placement in a child. J Neurosurg 101(Pediatrics 2):211-213
23. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P (2000) Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double blind study. Neurosurgery 46:603-609
24. Vassilyadi M, Farmer JP, Montes J (1995) Negative pressure hydrocephalus. J Neurosurg 83:486-490
25. Vender JR, Hester S, Waller J, Rekito A, Lee M (2006) Identification and management of intrathecal baclofen pump complications: A comparison of pediatric and adult patients. J Neurosurg 104(Pediatrics 1):9-15